Breaking News

Ajinomoto Althea Expands Bio-Mfg. Capabilities

Operations to include highly active materials including ADCs and HPAPIs

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Ajinomoto Althea, Inc. is expanding its existing biologic drug product manufacturing operations to include highly active materials including Antibody Drug Conjugates (ADCs) and HPAPIs (Highly Potent Active Pharmaceutical Ingredients). The new facility is located near Althea’s operations in San Diego, CA.    Oncology therapeutics such as ADCs and HPAPIs are among the fasting growing segments in the pharma industry, and require specialized manufacturing facilities and infrastructure to ensure sa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters